Knee replacement pain showdown: local injection vs nerve blocks
NCT ID NCT07477730
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study compares two pain relief methods for people undergoing total knee replacement: injecting numbing medicine into the knee area versus blocking several nerves around the knee. The goal is to see which method reduces the need for strong painkillers like opioids in the first 24 hours after surgery. The trial plans to enroll 80 adults who are otherwise healthy and live independently.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
ropivacaine
What this could lead to
If this trial succeeds, it could show that one pain relief method is better after knee replacement, potentially reducing opioid use and speeding up recovery.
What could go wrong
This is a small, early-stage trial with only 80 participants, so results may not apply to everyone. The study is not yet recruiting, and the open-label design could introduce bias.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TOTAL KNEE ARTHROPLASTY are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Clinique Médipôle Garonne
Toulouse, Haute-Garonne, 31036, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact